Integra LifeSciences Holdings Corporation

    Jurisdiction
    United States
    LEI
    WB7IJCYY8YFTENS4O147
    ISIN
    US4579852082 (IART)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. Read full profile

    Fundamentals

    Net revenue
    €1.38B
    Gross margin
    51.3%
    EBIT
    €10.22M
    EBIT margin
    0.7%
    Net income
    -€427.01M
    Net margin
    -30.9%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €1.48B +7.3% €158.15M -137.0%
    €1.54B +3.8% €179.21M +13.3%
    N/A N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Congress transactions

    Name Transaction date Value
    Josh Gottheimer July 9, 2024 $1.00K–$15.00K

    Earnings Calls

    Earnings Calls

    Latest earnings call: May 6, 2024 (Q1 2024)

    Add to watchlist

    Notifications